Envoke, a Leeds, UK-based lab simulator company, has secured £1.6 million in funding, bringing its total funding to more than £4 million.
Investors
The funding round was backed by existing investors NPIF – Mercia Equity Finance and Finance Yorkshire's Seedcorn Fund, alongside new investor Foresight Group.
Envoke Use of Funds
The company will use the funding to expand globally, strengthen its presence in the Asia-Pacific region, enhance its virtual laboratory training and maintenance platform, and create new jobs in the UK.
About Envoke
Founded in 2019 by Stuart Warrington, Envoke is a SaaS company that develops virtual simulation software for laboratory equipment training, troubleshooting, and maintenance. Its platform creates digital replicas of complex laboratory machines, enabling healthcare providers and equipment manufacturers to train staff remotely, reduce equipment downtime, and improve operational efficiency. Headquartered in Leeds, UK, Envoke’s customers include Bio-Rad, Thermo Fisher Scientific, PacBio, Haemonetics, the NHS, Mayo Clinic, and Hawai'i’s national blood laboratories.
Funding Details
Company: Envoke
Raised: £1.6M
Round: Seed
Funding Date: May 2026
Investors: NPIF – Mercia Equity Finance, Finance Yorkshire's Seedcorn Fund, Foresight Group
Company Website: https://envoke-demos.com/
Software Category: Laboratory Simulation & Healthcare Training Software
Source: Envoke